EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Long noncoding RNA H19 in liver development and disease

Diego Elias Montoya-Durango, Leila Gobejishvili

Cellular Signalling · 2026-06 · 142 · 112413

DOI: 10.1016/j.cellsig.2026.112413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-06. Verfasst von Diego Elias Montoya-Durango und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, United States of America; Alcohol Research Center, Unive…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Liver, Liver Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institutes of Health, Jewish Heritage Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver disease is a global health problem responsible for more than two million deaths annually. Metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD) are major contributors to chronic liver disease-related morbidity and mortality. Factors like diet and alcohol consumption have become key drivers of liver pathologies including steatosis, fibrosis/cirrhosis, and hepatocellular carcinoma. To date very few treatments are available, hence there is a critical need for the development of novel therapies to slow down the development/progression of liver damage. The long non-coding RNA H19 gene, H19, is an imprinted gene normally expressed from the maternally inherited chromosome and epigenetically silenced in the paternal chromosome. At the embryo stage H19 controls genome-wide methylation, directs the methylation of the imprinted gene network, and regulates organ size. In the livers of neonates, H19 is important for organ maturation but remains silent in the mature organ. H19 re-expression in the adult liver drives de novo lipogenesis and fibrosis and maintains a proliferative state in tumor cells. The complexity of H19 functions in the liver is reflected in its interaction and regulation of a growing number of proteins, and coding and non-coding RNAs involved in metabolism, pro-fibrotic gene networks, cell cycle progression, and chromatin regulation. This review summarizes the findings related to the role of H19 in liver development and in diseases such as fatty liver, fibrosis, and hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingLiverLiver DiseasesHumansAnimalsFatty LiverGenomic ImprintingLiver Neoplasms

Stichwörter der Autor:innen

FibrosisLipid metabolismLiverLiver cancerLiver injuryLong noncoding RNA H19

Substanzen

RNA, Long NoncodingH19 long non-coding RNA

Autor:innen und Institutionen

  • Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, United States of America; Alcohol Research Center, University of Louisville School of Medicine, Louisville, KY 40202, United S…

Förderung

  • NIAAA NIH HHS
  • National Institutes of Health
  • Jewish Heritage Fund
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Montoya-Durango, D. E., & Gobejishvili, L. (2026). Long noncoding RNA H19 in liver development and disease. Cellular Signalling, 142, 112413. https://doi.org/10.1016/j.cellsig.2026.112413

Vancouver

Montoya-Durango DE, Gobejishvili L. Long noncoding RNA H19 in liver development and disease. Cellular Signalling. 2026;142:112413. doi:10.1016/j.cellsig.2026.112413

BibTeX
@article{MontoyaDurango2026,
  author = {Montoya-Durango, Diego Elias and Gobejishvili, Leila},
  title = {Long noncoding RNA H19 in liver development and disease},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {142},
  pages = {112413},
  doi = {10.1016/j.cellsig.2026.112413}
}
Kostenlos starten →